Abstract
Purpose
It was to assess antiangiogenic effect of β-elemene in vitro and in vivo, and it was involved in inhibiting melanoma growth and metastasis, as well as to elucidate its intrinsic mechanism.
Methods
Inhibitive effect of β-elemene on B16F10 cells was performed by cell proliferation assay. Angiogenesis assays in vitro including rat aortic ring and chick embryo chorioallantoic membrane were used, as well as melanoma growth and metastasis assay in C57BL/6 mice. Vascular endothelial growth factor (VEGF) expression in vitro and in vivo was measured respectively by western blot analysis and enzyme-linked immunosorbent assay (ELISA). Immunohistochemistry analysis of CD34 and VEGF expression in primary melanoma was also presented.
Results
β-Elemene inhibited B16BF10 cell proliferation starting from 200 μM, but VEGF from 20 μM. Both 20 and 50 μM β-elemene in vitro inhibited VEGF-induced sprouting vessel of rat aortic ring and microvessel formation of chick embryo chorioallantoic membrane. In vivo, tumor size of primary melanoma in mice intraperitoneally treated with β-elemene was significantly smaller than that of the control; CD34 expression of primary melanoma was also suppressed; and the metastatic melanoma colonies and content of melanin in lung were detected obviously decreased in mice of β-elemene-treated groups. Furthermore, results of VEGF expressing in primary melanoma, serum and lung of mice also disclosed that VEGF was inhibited in vivo.
Conclusions
β-Elemene inhibited melanoma growth and metastasis through suppressing VEGF-mediated angiogenesis. It is a natural potential antiangiogenic agent.
Similar content being viewed by others
References
Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ (2000) Early detection and treatment of skin cancer. Am Fam Physician 62:357–368 375–356, 381–352
Jahng AW, Liao SS (2006) Successful palliation with octreotide of a neuroendocrine syndrome from malignant melanoma. J Pain Symptom Manage 32:191–195
Guadagnolo BA, Zagars GK (2009) Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol 10:409–416
Lorigan P, Eisen T, Hauschild A (2008) Systemic therapy for metastatic malignant melanoma–from deeply disappointing to bright future? Exp Dermatol 17:383–394
Berk LB (2008) Radiation therapy as primary and adjuvant treatment for local and regional melanoma. Cancer Control 15:233–238
Tuma RS (2008) Mechanisms of metastasis: theories focus on microenvironment, host factors, genes. J Natl Cancer Inst 100:1752–1754
Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–458
Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274–284
Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039–2049
Streit M, Detmar M (2003) Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 22:3172–3179
van Hinsbergh VW, Collen A, Koolwijk P (2001) Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 936:426–437
Zetter BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49:407–424
Lai EY, Chyau CC, Mau JL, Chen CC, Lai YJ (2004) Antimicrobial activity and cytotoxicity of the essential oil of Curcuma zedoaria. Am J Chin Med 32:281–290
Zhu R, Yang L, Shen L, Ye J, Liu J (2009) ANG II-AT1 receptor pathway is involved in the anti-fibrotic effect of beta-elemene. J Huazhong Univ Sci Technol Med Sci 29:177–181
Wang G, Li X, Huang F, Zhao J, Ding H (2005) Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62:881–893
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ (2008) Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 264:127–134
Nicosia RF, Ottinetti A (1990) Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63:115–122
Brooks PC, Montgomery AM, Cheresh DA (1999) Use of the 10-day-old chick embryo model for studying angiogenesis. Methods Mol Biol 129:257–269
Ito A, Morita N, Miura D, Koma Y, Kataoka TR (2004) A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells. Carcinogenesis 25:2015–2022
Boehm T, Folkman J, Browder T, O’Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404–407
Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med 324:1–8
Watts KP, Fairchild RG, Slatkin DN, Greenberg D, Packer S (1981) Melanin content of hamster tissues, human tissues, and various melanomas. Cancer Res 41:467–472
Li X, Wang G, Zhao J, Ding H, Cunningham C (2005) Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 62:894–904
Khosravi Shahi P, Fernandez Pineda I (2008) Tumoral angiogenesis: review of the literature. Cancer Invest 26:104–108
Stackpole CW, Alterman AL, Valle EF (1991) B16 melanoma variants selected by one or more cycles of spontaneous metastasis to the same organ fail to exhibit organ specificity. Clin Exp Metastasis 9:319–332
Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ (2004) Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Eur J Haematol 72:410–415
Vieira SC, Silva BB, Pinto GA, Vassallo J, Moraes NG (2005) CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol Res Pract 201:313–318
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6
Sridhar SS, Shepherd FA (2003) Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer. Lung Cancer 42(Suppl 1):S81–S91
Kerr DJ (2004) Targeting angiogenesis in cancer: clinical development of bevacizumab. Nat Clin Pract Oncol 1:39–43
Stein MN, Flaherty KT (2007) CCR drug updates: sorafenib and sunitinib in renal cell carcinoma. Clin Cancer Res 13:3765–3770
Wang Y, Fang MY, Jiang F, Peng HJ (2004) Effects of arsenic trioxide, ginseng saponin and beta-elemene on telomere-telomerase system in K562 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12:315–320
Xu YH, Dong B, Luo QZ, Zhou HY, Jia YC (2005) Influence of elemene on the expression of Bcl-2 family genes in rat C6 glioma cells. Zhonghua Yi Xue Za Zhi 85:1700–1703
Losordo DW, Isner JM (2001) Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 21:6–12
Xue Q, Nagy JA, Manseau EJ, Phung TL, Dvorak HF, Benjamin LE (2009) Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler Thromb Vasc Biol 29:1172–1178
Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, Costantini F, Murohara T, Takahashi M (2008) Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10:329–337
Matsumoto T, Claesson-Welsh L (2001) VEGF receptor signal transduction. Sci STKE 112:re21
Acknowledgments
This work was supported by National Natural Science Foundation of China (30801545), Jiangsu Administration of Chinese Medicine Foundation (HZ07052) and Nanjing University of Chinese Medicine Foundation (07XZR08).
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, W., Lu, Y., Wu, J. et al. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother Pharmacol 67, 799–808 (2011). https://doi.org/10.1007/s00280-010-1378-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-010-1378-x